title: [Hemolytic uremic syndrome in children].
authors.affiliation: Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France. Electronic address: s.cloarec@chu-tours.fr.
authors.forename: S
authors.initials: S
authors.lastname: Cloarec
authors.affiliation: Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France.
authors.forename: L
authors.initials: L
authors.lastname: Prat
authors.affiliation: Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France.
authors.forename: E
authors.initials: E
authors.lastname: Merieau
authors.affiliation: Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France.
authors.forename: S
authors.initials: S
authors.lastname: Benoit
authors.affiliation: Centre de compétence maladies rénales rares, Service de Néphrologie Pédiatrique, CHRU Clocheville, 49 Bd Béranger, 37000 Tours, France.
authors.forename: J-M
authors.initials: JM
authors.lastname: Halimi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D002648:Child; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D011379:Prognosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab